Beyond Structure: Defining the Function of the Gut Using Omic Approaches for Rational Design of Personalized Therapeutics

by Casey M. Theriot
Published 2018-03-01

Contribution of Inhibitory Metabolites and Competition for Nutrients to Colonization Resistance against <i>Clostridioides difficile </i>by Commensal <i>Clostridium</i>

by Amber D. Reed, Casey M. Theriot
Published 2021-02-01

Diversification of host bile acids by members of the gut microbiota

by Jenessa A. Winston, Casey M. Theriot
Published 2020-03-01

A Small Molecule-Screening Pipeline to Evaluate the Therapeutic Potential of 2-Aminoimidazole Molecules Against Clostridium difficile

by Rajani Thanissery, Daina Zeng, Raul G. Doyle, Casey M. Theriot
Published 2018-06-01

The Lactobacillus Bile Salt Hydrolase Repertoire Reveals Niche-Specific Adaptation

by Sarah O’Flaherty, Alexandra Briner Crawley, Casey M. Theriot, Rodolphe Barrangou
Published 2018-05-01

Bile salt hydrolases: Gatekeepers of bile acid metabolism and host-microbiome crosstalk in the gastrointestinal tract.

by Matthew H Foley, Sarah O'Flaherty, Rodolphe Barrangou, Casey M Theriot
Published 2019-03-01

Improving the Catalytic Activity of Hyperthermophilic Pyrococcus horikoshii Prolidase for Detoxification of Organophosphorus Nerve Agents over a Broad Range of Temperatures

by Casey M. Theriot, Rebecca L. Semcer, Saumil S. Shah, Amy M. Grunden
Published 2011-01-01

The complete Campylobacter jejuni transcriptome during colonization of a natural host determined by RNAseq.

by Michael E Taveirne, Casey M Theriot, Jonathan Livny, Victor J DiRita
Published 2013-01-01

Secondary bile acid ursodeoxycholic acid alters weight, the gut microbiota, and the bile acid pool in conventional mice.

by Jenessa A Winston, Alissa Rivera, Jingwei Cai, Andrew D Patterson, Casey M Theriot
Published 2021-01-01

Shifts in the Gut Metabolome and Clostridium difficile Transcriptome throughout Colonization and Infection in a Mouse Model

by Joshua R. Fletcher, Samantha Erwin, Cristina Lanzas, Casey M. Theriot, Sarah E. F. D'Orazio
Published 2018-03-01

Dosing Regimen of Enrofloxacin Impacts Intestinal Pharmacokinetics and the Fecal Microbiota in Steers

by Kaitlyn M. Ferguson, Megan E. Jacob, Casey M. Theriot, Benjamin J. Callahan, Timo Prange, Mark G. Papich, Derek M. Foster
Published 2018-09-01

Ceftiofur formulation differentially affects the intestinal drug concentration, resistance of fecal Escherichia coli, and the microbiome of steers.

by Derek M Foster, Megan E Jacob, Kyle A Farmer, Benjamin J Callahan, Casey M Theriot, Sophia Kathariou, Natalia Cernicchiaro, Timo Prange, Mark G Papich
Published 2019-01-01

Clostridioides difficile exploits toxin-mediated inflammation to alter the host nutritional landscape and exclude competitors from the gut microbiota

by Joshua R. Fletcher, Colleen M. Pike, Ruth J. Parsons, Alissa J. Rivera, Matthew H. Foley, Michael R. McLaren, Stephanie A. Montgomery, Casey M. Theriot
Published 2021-01-01

In Vivo Targeting of Clostridioides difficile Using Phage-Delivered CRISPR-Cas3 Antimicrobials

by Kurt Selle, Joshua R. Fletcher, Hannah Tuson, Daniel S. Schmitt, Lana McMillan, Gowrinarayani S. Vridhambal, Alissa J. Rivera, Stephanie A. Montgomery, Louis-Charles Fortier, Rodolphe Barrangou, Casey M. Theriot, David G. Ousterout
Published 2020-03-01